Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.

Saved in:
Bibliographic Details
Title: Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.
Authors: Larsen LV; Department of ORL Head & Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark., Mirebeau-Prunier D; Laboratoire de Biochimie et Biologie Moléculaire, CHU Angers, Université d'Angers, UMR CNRS 6015, INSERM U1083, MITOVASC, Angers, France., Imai T; Department of Breast & Endocrine Surgery, National Hospital Organization, Higashinagoya National Hospital, Nagoya, Japan., Alvarez-Escola C; Endocrinology and Nutrition Department, University Hospital 'La Paz', Madrid, Spain., Hasse-Lazar K; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Censi S; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy., Castroneves LA; Department of Endocrinology, Endocrine Oncology Unit, Instituto do Cancer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Sakurai A; Department of Medical Genetics and Genomics, Sapporo Medical University School of Medicine, Sapporo, Japan., Kihara M; Department of Surgery, Kuma Hospital, Kobe, Hyogo, Japan., Horiuchi K; Department of Breast and Endocrine Surgery, Tokyo Women's Medical University, Tokyo, Japan., Barbu VD; AP-HP, Sorbonne Université, Laboratoire Commun de Biologie et Génétique Moléculaires, Hôpital St Antoine & INSERM CRSA, Paris, France.; Réseau TenGen, Marseille, France., Borson-Chazot F; Réseau TenGen, Marseille, France.; Fédération d'Endocrinologie, Hospices Civils de Lyon, Université Lyon 1, France., Gimenez-Roqueplo AP; Réseau TenGen, Marseille, France.; Service de Génétique, AP-HP, Hôpital européen Georges Pompidou, Paris, France.; Université de Paris, PARCC, INSERM, Paris, France., Pigny P; Réseau TenGen, Marseille, France.; Laboratoire de Biochimie et Oncologie Moléculaire, CHU Lille, Lille, France., Pinson S; Réseau TenGen, Marseille, France.; Laboratoire de Génétique Moléculaire, CHU Lyon, Lyon, France., Wohllk N; Endocrine Section, Hospital del Salvador, Santiago de Chile, Department of Medicine, University of Chile, Santiago, Chile., Eng C; Genomic Medicine Institute, Lerner Research Institute and Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Aydogan BI; Department of Endocrinology And Metabolic Diseases, Ankara University School of Medicine, Ankara, Turkey., Saranath D; Department of Research Studies & Additional Projects, Cancer Patients Aid Association, Dr. Vithaldas Parmar Research & Medical Centre, Worli, Mumbai, India., Dvorakova S; Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic., Castinetti F; Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (INSERM), U1251, Marseille Medical Genetics (MMG), Marseille, France.; Department of Endocrinology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares de l'hypophyse HYPO, Marseille, France., Patocs A; HAS-SE Momentum Hereditary Endocrine Tumors Research Group, Semmelweis University, Budapest, Hungary., Bergant D; Department of Surgical Oncology, Institute of Oncology, Ljubljana, Slovenia., Links TP; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Peczkowska M; Department of Hypertension, Institute of Cardiology, Warsaw, Poland., Hoff AO; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Mian C; Endocrinology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy., Dwight T; Cancer Genetics, Kolling Institute, Royal North Shore Hospital and University of Sydney, Sydney, New South Wales, Australia., Jarzab B; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Neumann HPH; Section for Preventive Medicine, Medical Center-University of Freiburg, Faculty of Medicine, Albert Ludwigs-University of Freiburg, Freiburg, Germany., Robledo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain., Uchino S; Department of Endocrine Surgery, Noguchi Thyroid Clinic and Hospital Foundation, Beppu, Oita, Japan., Barlier A; Réseau TenGen, Marseille, France.; Aix Marseille Univ, APHM, INSERM, MMG, Laboratory of Molecular Biology, Hospital La Conception, Marseille, France., Godballe C; Department of ORL Head & Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark., Mathiesen JS; Department of ORL Head & Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Source: Endocrine connections [Endocr Connect] 2020 Jun; Vol. 9 (6), pp. 489-497.
Publication Type: Journal Article
Journal Info: Publisher: BioScientifica Country of Publication: England NLM ID: 101598413 Publication Model: Print Cited Medium: Print ISSN: 2049-3614 (Print) Linking ISSN: 20493614 NLM ISO Abbreviation: Endocr Connect Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2049-3614
DOI:10.1530/EC-20-0163